Growth Metrics

Biohaven (BHVN) Share-based Compensation (2021 - 2026)

Biohaven has reported Share-based Compensation over the past 6 years, most recently at $28.3 million for Q1 2026.

  • Quarterly results put Share-based Compensation at $28.3 million for Q1 2026, down 46.69% from a year ago — trailing twelve months through Mar 2026 was $70.6 million (down 51.65% YoY), and the annual figure for FY2024 was $72.0 million, changed.
  • Share-based Compensation reached $28.3 million in Q1 2026 per BHVN's latest filing, up from $21.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $101.4 million in Q4 2022 and bottomed at $1.8 million in Q1 2022.
  • Median Share-based Compensation over the past 5 years was $20.8 million (2025), compared with a mean of $29.3 million.
  • The largest annual shift saw Share-based Compensation surged 682.23% in 2022 before it crashed 73.78% in 2023.
  • Over 5 years, Share-based Compensation stood at $101.4 million in 2022, then tumbled by 95.61% to $4.5 million in 2023, then surged by 1440.01% to $68.6 million in 2024, then plummeted by 68.62% to $21.5 million in 2025, then surged by 31.35% to $28.3 million in 2026.
  • Business Quant data shows Share-based Compensation for BHVN at $28.3 million in Q1 2026, $21.5 million in Q3 2025, and $20.8 million in Q2 2025.